Beta
Lansoprazole
medication Under reviewA proton pump inhibitor (PPI) medication used to reduce stomach acid production.
Research summary
The human evidence base for lansoprazole is strong for acid suppression and symptom relief in GERD and other acid-related disorders, but those are treatment uses rather than benefits for healthy subjects. In healthy adults, pharmacology and safety data show predictable acid suppression and generally good short-term tolerability, with common adverse effects being mostly gastrointestinal or mild neurologic symptoms. For healthy human subjects specifically, there is little evidence of performance, cognitive, metabolic, or longevity benefits. The main research consensus is that lansoprazole is an effective prescription acid-suppressing drug with a known interaction profile and a generally acceptable short-term safety record, but it should not be treated as a supplement for optimization in healthy individuals.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
No reports yet
Be the first to report this effect and help the community.
Add Lansoprazole to your stack to report effects
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Gastroesophageal reflux disease — chronic acid reflux
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
Research (1 study)
Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
Colletti RB, Colletti JE, Rouster-Stevens KA, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!